Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystaline forms of HCV inhibitor

Crystaline forms of HCV inhibitor

US Patent 9469673 · Granted Oct 18, 2016

Estimated economic value: $227,835,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms an2025
Salts and pharmaceutical compositions thereof for the treatment of inflammatory 2025
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-flu2025
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,32024
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, 2024
Frequency detector for clock data recovery2024
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms an2024
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,32023
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,32023
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,32022
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-flu2022
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoq2022